News

Technology News

Celerus Diagnostics Launches New Antibodies

Wednesday, February 25, 2009 5:15:00 AM PDT | VentureDeal Staff
Carpinteria, California  --  Diagnostics company Celerus Diagnostics announced the launch of a second wave of antibodies for use in the company's Celerus Wave System.

Among the antibodies launched are those for the diseases of acute lymphoblastic leukemia, lymphatic and vascular endolethium tumors and gastrointestinal stromal tumors.

“As we continue to install systems, and with demand increasing, our laboratory is on track to release 12-15 new products quarterly in response to customer needs,” said Chief Scientific Officer Dr. Marc Key.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1